Fortfahren mit
SML2145
TD52
≥98% (HPLC)
Synonym(e):
N2,N3-bis(3-Ethynylphenyl)-2,3-quinoxalinediamine
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|
Über diesen Artikel
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
C#CC1=CC=CC(NC2=NC3=CC=CC=C3N=C2NC4=CC=CC(C#C)=C4)=C1
InChI key
SCUPZFSEJFWQIS-UHFFFAOYSA-N
Biochem/physiol Actions
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description ≥98% (HPLC) | description ≥98% (HPLC) | description ≥98% (HPLC) | description ≥95% (HPLC) |
| form powder | form powder | form powder | form powder |
| assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥95% (HPLC) |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| solubility DMSO: 2 mg/mL, clear | solubility DMSO: 2 mg/mL, clear | solubility DMSO: 2 mg/mL, clear | solubility DMSO: ≥10 mg/mL |
| color white to beige | color white to beige | color white to beige | color yellow |
CAS 1798328-24-1 cancer research reagent | - | 7-[cis-3-(1-Azetidinylmethyl)cyclobutyl]-5-[3-(phenylmethoxy)phenyl]-7H-pyrrolo[2,3-d]-pyrimidin-4-amine, AEW541 chemical structure, NVP-AEW541 10mg, NVP-AEW541 475489-16-8 CAS number, NVP-AEW541 5mg, NVP-AEW541 ATP-competitive IGF-1R inhibitor, NVP-AEW541 Sigma-Aldrich, NVP-AEW541 cancer research reagent, NVP-AEW541 inhibitor for cellular autophosphorylation, NVP-AEW541 pharmacological activity, high purity NVP-AEW541 for research, reversible insulin-like growth factor receptor inhibitor NVP-AEW541 | - |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.